Addressing Impurities in Active Pharmaceutical Ingredients During Development
Active pharmaceutical ingredients (APIs) can be compromised by impurities that affect product quality and safety. This article discusses types of impurities, their sources, detection methods, and strategies for mitigation during drug development.





